Childbearing in coagulation disorders: Genetics (F2 and F5)
Congenital clotting disorders can be identified by changes in certain genes that affect blood clotting. These genetic mutations can increase the risk of thrombosis during pregnancy.
The most common hereditary thrombophilias are factor V Leiden and factor II (prothrombin), affecting between 3% and 11% of the population.
Individuals with a genetic predisposition to these clotting disorders may be at increased risk for developing deep vein thrombosis during pregnancy due to the increase in estrogens. In addition, such mutations may lead to an increased risk of recurrent miscarriage and pregnancy complications.
A predisposition to thrombophilia due to genetic factors can be determined by testing the genes involved in the blood clotting process (factor II, factor V). The mutations detected are subsequently analyzed.
Depending on the results, a close monitoring program or preventive measures, such as administration of low-dose aspirin, may be initiated.
Genes studied: F2, F5
Mesenchymal stem cells for the treatment of cerebral palsy
Cerebral palsy is a lifelong disorder characterized by movement disorders and postural problems caused by non-progressive brain injuries. Although there is no cure, mesenchymal stem cell (MSC) therapies offer hope for treatment options to repair the central nervous system. Studies show that MSCs...
Read moreUltrasound via smartphone
During an ultrasound examination, high-frequency sound waves are sent through the body, which are reflected by tissues and organs as echoes. The sound wave power of ultrasound devices used in obstetrics is so low that they do not cause any short or long-term damage to the body.
Read more
Older age and well-being
Older age and well-being (Prof. Breymann comments on NZZ article from April 8, 2024) It is time that the topic of longevity, with all its sometimes obscure developments, was discussed and addressed seriously ("Eternal healthy life is a false promise", NZZ April 8,...
Read more